2049-2002 Screening compound: (2E)-1-{5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}-2-[(3,8,8-trimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)methylidene]hydrazine

2049-2002 Screening compound: (2E)-1-{5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}-2-[(3,8,8-trimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)methylidene]hydrazine
2049-2002 Screening compound: (2E)-1-{5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}-2-[(3,8,8-trimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)methylidene]hydrazine alternative view

Chemical Structure Depiction of ChemDiv screening compound 2049-2002
(2E)-1-{5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}-2-[(3,8,8-trimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)methylidene]hydrazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2049-2002

Molecular Formula

C24H30N6 (C24 H30 N6)

Compound Name

(2E)-1-{5-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-yl}-2-[(3,8,8-trimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)methylidene]hydrazine

IUPAC name

(2E)-1-{5-methyl-5H-[124]triazino[56-b]indol-3-yl}-2-[(388-trimethyl-12346788a-octahydronaphthalen-2-yl)methylidene]hydrazine

SMILES

CC(CC1=CCCC(C)(C)C1C1)C1/C=N/Nc1nc(n(C)c2c3cccc2)c3nn1

InChI

InChI=1S/C24H30N6/c1-15-12-16-8-7-11-24(2,3)19(16)13-17(15)14-25-28-23-26-22-21(27-29-23)18-9-5-6-10-20(18)30(22)4/h5-6,8-10,14-15,17,19H,7,11-13H2,1-4H3,(H,26,28,29)

InChI Key

NDSONPMOFYKBTC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01243190

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.54

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.728

Distribution Coefficient, logD

4.565

Water Solubility, LogSw

-4.67

Polar Surface Area

57.722

Acid Dissociation Constant (pKa)

14.26

Base Dissociation Constant (pKb)

2.03

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

50.00

2049-2002 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

DGK Inhibitors Library (10558 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2049-2002 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2049-2002?
Check Price and Availability of 2049-2002, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2049-2002 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2049-2002
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2049-2002
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2049-2002 available by request